Columbia Laboratories, Inc. (CBRX) Tops Q2 EPS Views
Columbia Laboratories, Inc. (NASDAQ: CBRX) reported Q2 EPS of $0.16, $0.17 better than the analyst estimate of ($0.01).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SYNNEX Corp. (SNX) Tops Q2 EPS by 6c; Issues Solid Q3 Outlook
- Herman Miller (MLHR) Tops Q4 EPS by 4c, Offers Q1 Guidance
- Finish Line (FINL) Tops Q1 EPS by 1c; Comps Rise 1.5%
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!